Equibles does not estimate personal net worth.
Get an email with a short summary when Inovio Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get INO alertsPeter D. Kies is recorded as CFO at Inovio Pharmaceuticals, Inc. (INO). The newest filing on record that lists Peter D. Kies as CFO at Inovio Pharmaceuticals, Inc. (INO) is dated April 7, 2026. The proxy statement of Inovio Pharmaceuticals, Inc. reports total compensation of $833,684 for Peter D. Kies in fiscal 2025, including a base salary of $514,604. Disclosed compensation is on record for 9 fiscal years. Peter D. Kies has spoken on 1 earnings call across 1 company, most recently for Inovio Pharmaceuticals, Inc. on March 12, 2026. Inovio Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inovio Pharmaceuticals, Inc. includes Jacqueline E. Shea (CEO, COO and Board Member), Jacqueline Shea (CEO, COO and Board Member), Simon X. Benito (Chairman and Board Member) and 6 others.
“Today, I'd like to provide an overview of Inovio's financial results for the fourth and full year of 2025. As Jackie noted, our primary goal is to advance INO 3107 towards approval, and we remain focused on directing resources and extending our CANIS runway towards a potential launch date in 2026.”
Start not stated–present
Last confirmed April 7, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $514,604 | $833,684 |
| 2024 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $506,806 | $940,072 |
| 2023 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $622,881 | $1,161,040 |
| 2022 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $518,552 | $1,618,468 |
| 2021 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $496,168 | $2,297,817 |
| 2020 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $445,639 | $2,153,905 |
| 2019 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $523,285 | $1,142,936 |
| 2018 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $449,886 | $1,331,612 |
| 2017 | Inovio Pharmaceuticals, Inc. (INO) | Chief Financial Officer | $452,777 | $1,447,387 |
